These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 800972

  • 1. The diuretic effect of muzolimine (Bay g 2821) on hepatogenic ascites.
    Heinrich F, Loew D, Dýcka J.
    Curr Med Res Opin; ; 4(10):706-15. PubMed ID: 800972
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
    Fuller RK, Khambatta PB, Gobezie GC.
    JAMA; 1977 Mar 07; 237(10):972-5. PubMed ID: 319263
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
    Pérez-Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, Rivera F, Rodés J.
    Gastroenterology; 1983 May 07; 84(5 Pt 1):961-8. PubMed ID: 6339312
    [Abstract] [Full Text] [Related]

  • 12. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V, Bosch J, Casamitjana R, Cabrera J, Rivera F, Rodés J.
    Gut; 1980 Oct 07; 21(10):855-9. PubMed ID: 7439805
    [Abstract] [Full Text] [Related]

  • 13. Predictive factors influencing the therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Ljubicić N, Kujundzić M, Banić M, Vrkljan M.
    Scand J Gastroenterol; 1998 Apr 07; 33(4):441-7. PubMed ID: 9605268
    [Abstract] [Full Text] [Related]

  • 14. Bumetanide, spironolactone and a combination of the two, in the treatment of ascites due to liver disease. A prospective, controlled, randomized trial.
    Sarin SK, Sachdev G, Mishra SP, Sundaram KR, Shrivastwa A, Talukdar V, Broor SL.
    Digestion; 1988 Apr 07; 41(2):101-7. PubMed ID: 3065101
    [Abstract] [Full Text] [Related]

  • 15. Muzolimine in chronic renal failure: a study in 16 patients.
    Stratta P, Dogliani M, Squiccimarro G, Colla L, Vercellone A.
    Z Kardiol; 1985 Apr 07; 74 Suppl 2():125-8. PubMed ID: 4002786
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.
    Fernández-Esparrach G, Guevara M, Sort P, Pardo A, Jiménez W, Ginès P, Planas R, Lebrec D, Geuvel A, Elewaut A, Adler M, Arroyo V.
    J Hepatol; 1997 Mar 07; 26(3):614-20. PubMed ID: 9075669
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Kosta P, Papadimitriou K, Tsianos EV.
    J Clin Gastroenterol; 2006 Apr 07; 40(4):342-6. PubMed ID: 16633107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.